Sign in

CIK 0001682852

  • Large accelerated filer

Moderna, Inc.

Sign in to watch
Ticker
MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813467528
Phone
+1 617-714-6500
Business address
325 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
Moderna Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$50,775,837
in 5 filings, $50.8M under 10b5-1 plans

Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-12-07 Andres Juan Exercise or conversion +2,000 $20.93 $42K 14,803
2022-12-07 Andres Juan Sale −2,000 $172.16 $344K 12,803
2022-12-07 Andres Juan Exercise or conversion · Stock Option (Right to Buy) −2,000 209,025
2022-12-07 Bancel Stephane Chief Executive Officer Exercise or conversion +40,000 $0.99 $40K 5,451,946
2022-12-07 Bancel Stephane Chief Executive Officer Sale −443 $175.26 $78K 5,451,503
2022-12-07 Bancel Stephane Chief Executive Officer Sale −7,613 $176.56 $1.3M 5,443,890
2022-12-07 Bancel Stephane Chief Executive Officer Sale −15,826 $177.30 $2.8M 5,428,064
2022-12-07 Bancel Stephane Chief Executive Officer Sale −4,961 $178.23 $884K 5,423,103
2022-12-07 Bancel Stephane Chief Executive Officer Sale −10,557 $179.49 $1.9M 5,412,546
2022-12-07 Bancel Stephane Chief Executive Officer Sale −600 $180.11 $108K 5,411,946
2022-12-07 Bancel Stephane Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −40,000 2,307,155
2022-12-07 Klinger Shannon Thyme Chief Legal Officer Exercise or conversion +1,139 5,262
2022-12-07 Klinger Shannon Thyme Chief Legal Officer Exercise or conversion · Restricted Stock Units −1,139 11,386
2022-12-07 AFEYAN NOUBAR Director Sale −10,000 $172.16 $1.7M 2,297,209

Page 66 of 66 · 1,314 trades